Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

A Combined Offline and Online Algorithm for Real-Time and Long-Term Classification of Sheep Behaviour: Novel Approach for Precision Livestock Farming.

Vázquez-Diosdado JA, Paul V, Ellis KA, Coates D, Loomba R, Kaler J.

Sensors (Basel). 2019 Jul 20;19(14). pii: E3201. doi: 10.3390/s19143201.

2.

Effect of a 24-month physical activity program on brain changes in older adults at risk of Alzheimer's disease: the AIBL active trial.

Venkatraman VK, Sanderson A, Cox KL, Ellis KA, Steward C, Phal PM, Gorelik A, Sharman MJ, Villemagne VL, Lai M, Cyarto EV, Merkel B, Ames D, Szoeke C, Rowe CC, Masters CL, Lautenschlager NT, Desmond PM.

Neurobiol Aging. 2019 May 27. pii: S0197-4580(19)30155-1. doi: 10.1016/j.neurobiolaging.2019.02.030. [Epub ahead of print]

PMID:
31324405
3.

Distinct effects of acute exercise and breaks in sitting on working memory and executive function in older adults: a three-arm, randomised cross-over trial to evaluate the effects of exercise with and without breaks in sitting on cognition.

Wheeler MJ, Green DJ, Ellis KA, Cerin E, Heinonen I, Naylor LH, Larsen R, Wennberg P, Boraxbekk CJ, Lewis J, Eikelis N, Lautenschlager NT, Kingwell BA, Lambert G, Owen N, Dunstan DW.

Br J Sports Med. 2019 Apr 29. pii: bjsports-2018-100168. doi: 10.1136/bjsports-2018-100168. [Epub ahead of print]

PMID:
31036563
4.

Targeted physical activity for older adults with mild cognitive impairment and subjective cognitive decline.

You E, Ellis KA, Cox K, Lautenschlager NT.

Med J Aust. 2019 May;210(9):394-395.e1. doi: 10.5694/mja2.50153. Epub 2019 Apr 25. No abstract available.

PMID:
31020997
5.

Effect of Morning Exercise With or Without Breaks in Prolonged Sitting on Blood Pressure in Older Overweight/Obese Adults.

Wheeler MJ, Dunstan DW, Ellis KA, Cerin E, Phillips S, Lambert G, Naylor LH, Dempsey PC, Kingwell BA, Green DJ.

Hypertension. 2019 Apr;73(4):859-867. doi: 10.1161/HYPERTENSIONAHA.118.12373.

PMID:
30782027
6.

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease.

Ashton NJ, Nevado-Holgado AJ, Barber IS, Lynham S, Gupta V, Chatterjee P, Goozee K, Hone E, Pedrini S, Blennow K, Schöll M, Zetterberg H, Ellis KA, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Aarsland D, Powell J, Lovestone S, Martins R, Hye A.

Sci Adv. 2019 Feb 6;5(2):eaau7220. doi: 10.1126/sciadv.aau7220. eCollection 2019 Feb.

7.

Morning exercise mitigates the impact of prolonged sitting on cerebral blood flow in older adults.

Wheeler MJ, Dunstan DW, Smith B, Smith KJ, Scheer A, Lewis J, Naylor LH, Heinonen I, Ellis KA, Cerin E, Ainslie PN, Green DJ.

J Appl Physiol (1985). 2019 Apr 1;126(4):1049-1055. doi: 10.1152/japplphysiol.00001.2019. Epub 2019 Feb 7.

PMID:
30730813
8.

A Randomized Controlled Trial of Adherence to a 24-Month Home-Based Physical Activity Program and the Health Benefits for Older Adults at Risk of Alzheimer's Disease: The AIBL Active-Study.

Cox KL, Cyarto EV, Ellis KA, Ames D, Desmond P, Phal P, Sharman MJ, Szoeke C, Rowe CC, Masters CL, You E, Burrows S, Lai MMY, Lautenschlager NT.

J Alzheimers Dis. 2018 Oct 26. doi: 10.3233/JAD-180521. [Epub ahead of print]

PMID:
30372680
9.

Divergent gene expression among phytoplankton taxa in response to upwelling.

Lampe RH, Cohen NR, Ellis KA, Bruland KW, Maldonado MT, Peterson TD, Till CP, Brzezinski MA, Bargu S, Thamatrakoln K, Kuzminov FI, Twining BS, Marchetti A.

Environ Microbiol. 2018 Aug;20(8):3069-3082. doi: 10.1111/1462-2920.14361. Epub 2018 Sep 10.

PMID:
30043484
10.

Postpartum ketoprofen treatment does not alter stress biomarkers in cows and calves experiencing assisted and unassisted parturition: a randomised controlled trial.

Gladden N, McKeegan D, Viora L, Ellis KA.

Vet Rec. 2018 Oct 6;183(13):414. doi: 10.1136/vr.104913. Epub 2018 Jun 30.

PMID:
29960984
11.

Trajectories of irregular word reading ability as a proxy for premorbid intelligence in Alzheimer's disease, mild cognitive impairment, and healthy aging: A longitudinal study.

Weinborn M, Bucks RS, Sohrabi HR, Rainey-Smith SR, Brown BM, Gardener SL, Gozt A, Christensen D, Savage G, Laws SM, Taddei K, Maruff P, Robertson JS, Ellis KA, Ames D, Masters CL, Rowe CC, Martins RN.

Psychol Assess. 2018 Oct;30(10):1308-1316. doi: 10.1037/pas0000565. Epub 2018 May 21.

12.

Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.

Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D.

Alzheimer Dis Assoc Disord. 2018 Jul-Sep;32(3):190-196. doi: 10.1097/WAD.0000000000000252.

PMID:
29561277
13.

Evaluation of sampling frequency, window size and sensor position for classification of sheep behaviour.

Walton E, Casey C, Mitsch J, Vázquez-Diosdado JA, Yan J, Dottorini T, Ellis KA, Winterlich A, Kaler J.

R Soc Open Sci. 2018 Feb 7;5(2):171442. doi: 10.1098/rsos.171442. eCollection 2018 Feb.

14.

Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.

Doecke JD, Rembach A, Villemagne VL, Varghese S, Rainey-Smith S, Sarros S, Evered LA, Fowler CJ, Pertile KK, Rumble RL, Trounson B, Taddei K, Laws SM, Macaulay SL, Bush AI, Ellis KA, Martins R, Ames D, Silbert B, Vanderstichele H, Masters CL, Darby DG, Li QX, Collins S; AIBL Research Group.

J Alzheimers Dis. 2018;61(1):169-183. doi: 10.3233/JAD-170128.

PMID:
29171991
15.

Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health.

Wheeler MJ, Dempsey PC, Grace MS, Ellis KA, Gardiner PA, Green DJ, Dunstan DW.

Alzheimers Dement (N Y). 2017 May 2;3(3):291-300. doi: 10.1016/j.trci.2017.04.001. eCollection 2017 Sep. Review.

16.

Targeted anthelmintic treatment of parasitic gastroenteritis in first grazing season dairy calves using daily live weight gain as an indicator.

Jackson A, Ellis KA, McGoldrick J, Jonsson NN, Stear MJ, Forbes AB.

Vet Parasitol. 2017 Sep 15;244:85-90. doi: 10.1016/j.vetpar.2017.07.023. Epub 2017 Jul 24.

PMID:
28917324
17.

A randomized controlled trial of physical activity with individual goal-setting and volunteer mentors to overcome sedentary lifestyle in older adults at risk of cognitive decline: the INDIGO trial protocol.

Cox KL, Cyarto EV, Etherton-Beer C, Ellis KA, Alfonso H, Clare L, Liew D, Ames D, Flicker L, Almeida OP, LoGiudice D, Lautenschlager NT.

BMC Geriatr. 2017 Sep 13;17(1):215. doi: 10.1186/s12877-017-0617-y.

18.

A 'Disease Severity Index' to identify individuals with Subjective Memory Decline who will progress to mild cognitive impairment or dementia.

Ferreira D, Falahati F, Linden C, Buckley RF, Ellis KA, Savage G, Villemagne VL, Rowe CC, Ames D, Simmons A, Westman E.

Sci Rep. 2017 Mar 13;7:44368. doi: 10.1038/srep44368.

19.

Cobalamin-independent Methionine Synthase Distribution and Influence on Vitamin B12 Growth Requirements in Marine Diatoms.

Ellis KA, Cohen NR, Moreno C, Marchetti A.

Protist. 2017 Feb;168(1):32-47. doi: 10.1016/j.protis.2016.10.007. Epub 2016 Oct 25.

PMID:
27951467
20.

Implementation of subjective cognitive decline criteria in research studies.

Molinuevo JL, Rabin LA, Amariglio R, Buckley R, Dubois B, Ellis KA, Ewers M, Hampel H, Klöppel S, Rami L, Reisberg B, Saykin AJ, Sikkes S, Smart CM, Snitz BE, Sperling R, van der Flier WM, Wagner M, Jessen F; Subjective Cognitive Decline Initiative (SCD-I) Working Group.

Alzheimers Dement. 2017 Mar;13(3):296-311. doi: 10.1016/j.jalz.2016.09.012. Epub 2016 Nov 5.

21.

Alterations in dorsal and ventral posterior cingulate connectivity in APOE ε4 carriers at risk of Alzheimer's disease.

Kerestes R, Phal PM, Steward C, Moffat BA, Salinas S, Cox KL, Ellis KA, Cyarto EV, Ames D, Martins RN, Masters CL, Rowe CC, Sharman MJ, Salvado O, Szoeke C, Lai M, Lautenschlager NT, Desmond PM.

BJPsych Open. 2015 Nov 9;1(2):139-148. eCollection 2015 Oct.

22.

Associations of neighborhood environment with brain imaging outcomes in the Australian Imaging, Biomarkers and Lifestyle cohort.

Cerin E, Rainey-Smith SR, Ames D, Lautenschlager NT, Macaulay SL, Fowler C, Robertson JS, Rowe CC, Maruff P, Martins RN, Masters CL, Ellis KA.

Alzheimers Dement. 2017 Apr;13(4):388-398. doi: 10.1016/j.jalz.2016.06.2364. Epub 2016 Aug 19.

PMID:
27546307
23.

A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease.

Buckley RF, Villemagne VL, Masters CL, Ellis KA, Rowe CC, Johnson K, Sperling R, Amariglio R.

J Mol Neurosci. 2016 Nov;60(3):354-361. Epub 2016 Aug 11. Review.

24.

Crystal structure of [tris-(pyridin-2-ylmeth-yl)amine-κ(4) N]copper(II) bromide.

Bridgman EC, Doherty MM, Ellis KA, Homer EA, Lashbrook TN, Mraz ME, Pernesky GC, Vreeke EM, Oshin KD, Oliver AG.

Acta Crystallogr E Crystallogr Commun. 2016 May 10;72(Pt 6):801-4. doi: 10.1107/S2056989016007568. eCollection 2016 Jun 1.

25.

Urethral Foreign Bodies: Clinical Presentation and Management.

Palmer CJ, Houlihan M, Psutka SP, Ellis KA, Vidal P, Hollowell CM.

Urology. 2016 Nov;97:257-260. doi: 10.1016/j.urology.2016.05.045. Epub 2016 May 31.

PMID:
27261182
26.

Why attend a memory clinic? What do patients and their families want and/or expect?

Mastwyk M, Dow B, Ellis KA, Ames D.

Australas J Ageing. 2016 Sep;35(3):220-4. doi: 10.1111/ajag.12257. Epub 2016 Mar 11.

PMID:
26970418
27.

Acute effects of breaking up prolonged sitting on fatigue and cognition: a pilot study.

Wennberg P, Boraxbekk CJ, Wheeler M, Howard B, Dempsey PC, Lambert G, Eikelis N, Larsen R, Sethi P, Occleston J, Hernestål-Boman J, Ellis KA, Owen N, Dunstan DW.

BMJ Open. 2016 Feb 26;6(2):e009630. doi: 10.1136/bmjopen-2015-009630.

28.

Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease.

Buckley RF, Maruff P, Ames D, Bourgeat P, Martins RN, Masters CL, Rainey-Smith S, Lautenschlager N, Rowe CC, Savage G, Villemagne VL, Ellis KA; AIBL study.

Alzheimers Dement. 2016 Jul;12(7):796-804. doi: 10.1016/j.jalz.2015.12.013. Epub 2016 Feb 4.

PMID:
26852195
29.

Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.

Zwan MD, Villemagne VL, Doré V, Buckley R, Bourgeat P, Veljanoski R, Salvado O, Williams R, Margison L, Rembach A, Macaulay SL, Martins R, Ames D, van der Flier WM, Ellis KA, Scheltens P, Masters CL, Rowe CC.

J Alzheimers Dis. 2016;49(4):1115-22. doi: 10.3233/JAD-150446.

PMID:
26639956
30.

Standardizing communication from acute care providers to primary care providers on critically ill adults.

Ellis KA, Connolly A, Hosseinnezhad A, Lilly CM.

Am J Crit Care. 2015 Nov;24(6):496-500. doi: 10.4037/ajcc2015332.

31.

Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months.

Thai C, Lim YY, Villemagne VL, Laws SM, Ames D, Ellis KA, Rainey-Smith SR, Martins RN, Masters CL, Rowe CC, Maruff P; Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group.

PLoS One. 2015 Oct 2;10(10):e0139082. doi: 10.1371/journal.pone.0139082. eCollection 2015.

32.

Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies.

Rabin LA, Smart CM, Crane PK, Amariglio RE, Berman LM, Boada M, Buckley RF, Chételat G, Dubois B, Ellis KA, Gifford KA, Jefferson AL, Jessen F, Katz MJ, Lipton RB, Luck T, Maruff P, Mielke MM, Molinuevo JL, Naeem F, Perrotin A, Petersen RC, Rami L, Reisberg B, Rentz DM, Riedel-Heller SG, Risacher SL, Rodriguez O, Sachdev PS, Saykin AJ, Slavin MJ, Snitz BE, Sperling RA, Tandetnik C, van der Flier WM, Wagner M, Wolfsgruber S, Sikkes SA.

J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S63-86. doi: 10.3233/JAD-150154.

33.

Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.

Li QX, Villemagne VL, Doecke JD, Rembach A, Sarros S, Varghese S, McGlade A, Laughton KM, Pertile KK, Fowler CJ, Rumble RL, Trounson BO, Taddei K, Rainey-Smith SR, Laws SM, Robertson JS, Evered LA, Silbert B, Ellis KA, Rowe CC, Macaulay SL, Darby D, Martins RN, Ames D, Masters CL, Collins S; AIBL Research Group.

J Alzheimers Dis. 2015;48(1):175-87. doi: 10.3233/JAD-150247.

PMID:
26401938
34.

Comparative analysis of the Cancer Council of Victoria and the online Commonwealth Scientific and Industrial Research Organisation FFQ.

Gardener SL, Rainey-Smith SR, Macaulay SL, Taddei K, Rembach A, Maruff P, Ellis KA, Masters CL, Rowe CC, Ames D, Keogh JB, Martins RN; AIBL Research Group.

Br J Nutr. 2015 Nov 28;114(10):1683-93. doi: 10.1017/S0007114515003335. Epub 2015 Sep 18.

PMID:
26382226
35.
36.

Semi-automated hippocampal segmentation in people with cognitive impairment using an age appropriate template for registration.

Merkel B, Steward C, Vivash L, Malpas CB, Phal P, Moffat BA, Cox KL, Ellis KA, Ames DJ, Cyarto EV, Lai MM, Sharman MJ, Szoeke C, Masters CL, Lautenschlager NT, Desmond P.

J Magn Reson Imaging. 2015 Dec;42(6):1631-8. doi: 10.1002/jmri.24966. Epub 2015 Jul 3.

PMID:
26140584
37.

Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 status.

Albrecht MA, Szoeke C, Maruff P, Savage G, Lautenschlager NT, Ellis KA, Taddei K, Martins R, Masters CL, Ames D, Foster JK; AIBL Research Group.

Neuropsychologia. 2015 Aug;75:411-9. doi: 10.1016/j.neuropsychologia.2015.06.008. Epub 2015 Jun 20.

PMID:
26102189
38.

Comparing the Performance of the HADS and the GDS-15 in the AIBL Study.

Campbell G, Bryant C, Ellis KA, Buckley R, Ames D; AIBL RESEARCH GROUP.

Int Psychogeriatr. 2015 Sep;27(9):1577-8. doi: 10.1017/S1041610215000769. Epub 2015 Jun 3. No abstract available.

PMID:
26037212
39.

Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease.

Buckley RF, Ellis KA, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Villemagne VL, Macaulay SL, Szoeke C, Martins RN, Masters CL, Savage G, Rainey-Smith SR, Rembach A, Saling MM; Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) Research Group.

Neuropsychology. 2015 Jul;29(4):571-81. doi: 10.1037/neu0000156. Epub 2015 Feb 9.

PMID:
25664464
40.

Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.

Pietrzak RH, Lim YY, Neumeister A, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Restrepo C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P; Australian Imaging, Biomarkers, and Lifestyle Research Group.

JAMA Psychiatry. 2015 Mar;72(3):284-91. doi: 10.1001/jamapsychiatry.2014.2476.

PMID:
25629787
41.

APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.

Lim YY, Villemagne VL, Pietrzak RH, Ames D, Ellis KA, Harrington K, Snyder PJ, Martins RN, Masters CL, Rowe CC, Maruff P; Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group.

Neurobiol Aging. 2015 Mar;36(3):1239-44. doi: 10.1016/j.neurobiolaging.2014.12.008. Epub 2014 Dec 11.

PMID:
25559335
42.

Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease.

Johnson P, Vandewater L, Wilson W, Maruff P, Savage G, Graham P, Macaulay LS, Ellis KA, Szoeke C, Martins RN, Rowe CC, Masters CL, Ames D, Zhang P.

BMC Bioinformatics. 2014;15 Suppl 16:S11. doi: 10.1186/1471-2105-15-S16-S11. Epub 2014 Dec 8.

43.

Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.

Lim YY, Pietrzak RH, Bourgeat P, Ames D, Ellis KA, Rembach A, Harrington K, Salvado O, Martins RN, Snyder PJ, Masters CL, Rowe CC, Villemagne VL, Maruff P.

Arch Clin Neuropsychol. 2015 Feb;30(1):49-58. doi: 10.1093/arclin/acu068. Epub 2014 Dec 2.

PMID:
25467942
44.

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.

Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Rembach A, Martins RN, Rowe CC, Masters CL, Maruff P.

Mol Psychiatry. 2015 Nov;20(11):1322-8. doi: 10.1038/mp.2014.123. Epub 2014 Oct 7.

45.

Influence of BDNF Val66Met on the relationship between physical activity and brain volume.

Brown BM, Bourgeat P, Peiffer JJ, Burnham S, Laws SM, Rainey-Smith SR, Bartrés-Faz D, Villemagne VL, Taddei K, Rembach A, Bush A, Ellis KA, Macaulay SL, Rowe CC, Ames D, Masters CL, Maruff P, Martins RN; AIBL Research Group.

Neurology. 2014 Oct 7;83(15):1345-52. doi: 10.1212/WNL.0000000000000867. Epub 2014 Sep 3.

PMID:
25186863
46.

Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults.

Hollands S, Lim YY, Buckley R, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Lautenschlager N, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P.

J Alzheimers Dis. 2015;43(2):677-86. doi: 10.3233/JAD-140678.

PMID:
25114076
47.

Dietary patterns and cognitive decline in an Australian study of ageing.

Gardener SL, Rainey-Smith SR, Barnes MB, Sohrabi HR, Weinborn M, Lim YY, Harrington K, Taddei K, Gu Y, Rembach A, Szoeke C, Ellis KA, Masters CL, Macaulay SL, Rowe CC, Ames D, Keogh JB, Scarmeas N, Martins RN.

Mol Psychiatry. 2015 Jul;20(7):860-6. doi: 10.1038/mp.2014.79. Epub 2014 Jul 29.

PMID:
25070537
48.

Autobiographical narratives relate to Alzheimer's disease biomarkers in older adults.

Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Villemagne VL, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Szoeke C, Masters CL, Rainey-Smith SR, Rembach A, Savage G, Ellis KA; Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) Research Group.

Int Psychogeriatr. 2014 Oct;26(10):1737-46. doi: 10.1017/S1041610214001136. Epub 2014 Jun 27.

49.

An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation.

Rembach A, Watt AD, Wilson WJ, Rainey-Smith S, Ellis KA, Rowe CC, Villemagne VL, Macaulay SL, Bush AI, Martins RN, Ames D, Masters CL, Doecke JD; AIBL Research Group.

J Neuroimmunol. 2014 Aug 15;273(1-2):65-71. doi: 10.1016/j.jneuroim.2014.05.005. Epub 2014 May 20.

PMID:
24907904
50.

Response to comment on Moore et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes care 2013;36:2981-2987.

Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H, Woodward M, Ellis KA, Bush AI, Faux NG, Watters DA.

Diabetes Care. 2014 Jun;37(6):e151. doi: 10.2337/dc14-0278. No abstract available.

PMID:
24855179

Supplemental Content

Loading ...
Support Center